VAIM GLOBAL Successfully Hosts the ‘2025 JUPITER International Symposium’

VAIM GLOBAL Successfully Hosts the ‘2025 JUPITER International Symposium’

VAIM GLOBAL hosted the ‘2025 JUPITER (Juvelook Private Invitation Training & Education Round) International Symposium’ on March 1–2 at the Inspire Hotel in Incheon. The event brought together over 250 medical professionals from around the world to exchange insights on the latest research and clinical applications of JUVELOOK and LENISNA.

On the first day, sessions covered topics such as the scientific foundation and benefits of JUVELOOK, procedural safety, and clinical efficacy in wrinkle improvement. Professor Vasanop Vachiramon presented a study using a rabbit ear vascular injection model, demonstrating that JUVELOOK and LENISNA do not cause vascular occlusion. Additionally, Professor Hye-Seong Kim shared the results of a facial split-face study, proving the wrinkle improvement effects of JUVELOOK.

The second day featured discussions on skin regeneration, pigmentation treatment, and expert panel insights. Professor Byung-Hee Byun introduced research on JUVELOOK’s role in basement membrane regeneration and its potential for preventing and improving pigmentation. A panel of four specialists, including international and domestic dermatologists, further discussed clinical applications and best practices.

A VAIM GLOBAL representative stated, “As a leading brand in the global biostimulator market, we are committed to continuous research and clinical investment. We will continue to drive innovation and academic exchange to advance the medical aesthetics industry.”

Introduction of VAIM
Founded in 2014, VAIM is a global medical aesthetics company that develops human tissue regeneration products and improved pharmaceuticals by utilizing its accumulated technology and know-how in biocompatible and biodegradable polymers. It has developed and patented a PDLLA-based manufacturing technology that reduces the risk of nodule formation compared to other ingredient structures, and in 2019, its subsidiary, VAIM Global, entered the skin booster market with JUVELOOK, which utilizes this technology. JUVELOOK is a collagen booster that induces the production of ECM (collagen, elastin) to provide direct remodeling effects on the skin such as elasticity and wrinkle improvement, and is divided into JUVELOOK and LENISNA depending on the purpose. After quickly proving its safety and effectiveness since its launch, VAIM Global currently has product export contracts with 72 countries.